136 related articles for article (PubMed ID: 22057179)
1. Melatonin in Chagas' disease. Possible therapeutic value.
Cardinali DP; Alvarez CB
Medicina (B Aires); 2011; 71(5):477-83. PubMed ID: 22057179
[TBL] [Abstract][Full Text] [Related]
2. Suppressive action of melatonin on the TH-2 immune response in rats infected with Trypanosoma cruzi.
Santello FH; Frare EO; dos Santos CD; Caetano LC; Alonso Toldo MP; do Prado JC
J Pineal Res; 2008 Oct; 45(3):291-6. PubMed ID: 18373553
[TBL] [Abstract][Full Text] [Related]
3. Melatonin and zinc treatment: distinctive modulation of cytokine production in chronic experimental Trypanosoma cruzi infection.
Brazão V; Del Vecchio Filipin M; Santello FH; Caetano LC; Abrahão AA; Toldo MP; do Prado JC
Cytokine; 2011 Dec; 56(3):627-32. PubMed ID: 21944888
[TBL] [Abstract][Full Text] [Related]
4. Melatonin enhances pro-inflammatory cytokine levels and protects against Chagas disease.
Santello FH; Frare EO; Caetano LC; AlonsoToldo MP; do Prado JC
J Pineal Res; 2008 Aug; 45(1):79-85. PubMed ID: 18284549
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-17, oxidative stress, and inflammation: role of melatonin during Trypanosoma cruzi infection.
Brazão V; Colato RP; Santello FH; Filipin Mdel V; Toldo MP; do Vale GT; Tirapelli CR; do Prado Júnior JC
J Pineal Res; 2015 Nov; 59(4):488-96. PubMed ID: 26432539
[TBL] [Abstract][Full Text] [Related]
6. Melatonin and dehydroepiandrosterone combination: does this treatment exert a synergistic effect during experimental Trypanosoma cruzi infection?
Kuehn CC; Rodrigues Oliveira LG; Santos CD; Ferreira DS; Alonso Toldo MP; de Albuquerque S; do Prado JC
J Pineal Res; 2009 Oct; 47(3):253-9. PubMed ID: 19732300
[TBL] [Abstract][Full Text] [Related]
7. Trypanosoma cruzi: dehydroepiandrosterone (DHEA) and immune response during the chronic phase of the experimental Chagas' disease.
Caetano LC; Santello FH; Del Vecchio Filipin M; Brazão V; Caetano LN; Toldo MP; Caldeira JC; do Prado Júnior JC
Vet Parasitol; 2009 Jul; 163(1-2):27-32. PubMed ID: 19446400
[TBL] [Abstract][Full Text] [Related]
8. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
Laucella SA; Rottenberg ME; de Titto EH
Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488
[TBL] [Abstract][Full Text] [Related]
9. [The chemotherapy of Chagas disease].
Stoppani AO
Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
[TBL] [Abstract][Full Text] [Related]
10. Enalapril prevents cardiac immune-mediated damage and exerts anti-Trypanosoma cruzi activity during acute phase of experimental Chagas disease.
de Paula Costa G; Silva RR; Pedrosa MC; Pinho V; de Lima WG; Teixeira MM; Bahia MT; Talvani A
Parasite Immunol; 2010 Mar; 32(3):202-8. PubMed ID: 20398183
[TBL] [Abstract][Full Text] [Related]
11. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection.
Malvezi AD; Cecchini R; de Souza F; Tadokoro CE; Rizzo LV; Pinge-Filho P
FEMS Immunol Med Microbiol; 2004 May; 41(1):69-77. PubMed ID: 15094169
[TBL] [Abstract][Full Text] [Related]
12. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
Braun M; de Titto E
Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
[TBL] [Abstract][Full Text] [Related]
13. Protective actions of melatonin against heart damage during chronic Chagas disease.
Oliveira LG; Kuehn CC; dos Santos CD; Miranda MA; da Costa CM; Mendonça VJ; do Prado Júnior JC
Acta Trop; 2013 Dec; 128(3):652-8. PubMed ID: 24055715
[TBL] [Abstract][Full Text] [Related]
14. Does orchiectomy enhance the immune-stimulatory effects of melatonin during experimental Chagas' disease?
Santello FH; Caetano LC; Filipin Mdel V; Brazão V; Caetano LN; Toldo MP; do Prado JC
Res Vet Sci; 2012 Oct; 93(2):819-25. PubMed ID: 22177576
[TBL] [Abstract][Full Text] [Related]
15. Immunoregulatory actions of melatonin and zinc during chronic Trypanosoma cruzi infection.
Brazão V; Santello FH; Filipin Mdel V; Azevedo AP; Toldo MP; de Morais FR; do Prado JC
J Pineal Res; 2015 Mar; 58(2):210-8. PubMed ID: 25611919
[TBL] [Abstract][Full Text] [Related]
16. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
17. [Chagas' disease and its significance for Central and South America (author's transl)].
Berning H
MMW Munch Med Wochenschr; 1981 Jan; 123(1):23-6. PubMed ID: 6780884
[TBL] [Abstract][Full Text] [Related]
18. Rat models to investigate host macrophage defense against Trypanosoma cruzi.
Fabrino DL; Leon LL; Genestra M; Parreira GG; Melo RC
J Innate Immun; 2011; 3(1):71-82. PubMed ID: 21051863
[TBL] [Abstract][Full Text] [Related]
19. 5-Lipoxygenase plays a role in the control of parasite burden and contributes to oxidative damage of erythrocytes in murine Chagas' disease.
Borges CL; Cecchini R; Tatakihara VL; Malvezi AD; Yamada-Ogatta SF; Rizzo LV; Pinge-Filho P
Immunol Lett; 2009 Mar; 123(1):38-45. PubMed ID: 19428550
[TBL] [Abstract][Full Text] [Related]
20. Prolactin: does it exert an up-modulation of the immune response in Trypanosoma cruzi-infected rats?
Filipin Mdel V; Brazão V; Santello FH; Caetano LC; Toldo MP; do Prado JC
Vet Parasitol; 2011 Sep; 181(2-4):139-45. PubMed ID: 21570187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
